| P2093 | author name string | Feng Xing | |
| | Lijin Feng | |
| | Ning Luo | |
| | Cong Sun | |
| | Zhongping Cheng | |
| | Mengmeng Chen | |
| | Siyu Ding | |
| | Chenghua Liu | |
| | Yuanying He | |
| P2860 | cites work | The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges | Q26851852 |
| | Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. | Q33960065 |
| | NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells | Q34000632 |
| | Cisplatin in cancer therapy: molecular mechanisms of action | Q34098163 |
| | Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. | Q34184917 |
| | Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome | Q35032772 |
| | Synergistic inhibitory effect of wogonin and low-dose paclitaxel on gastric cancer cells and tumor xenografts | Q35047380 |
| | The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells | Q35247181 |
| | Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells | Q35878495 |
| | AKT inhibition mitigates GRP78 (glucose-regulated protein) expression and contribution to chemoresistance in endometrial cancers | Q36788196 |
| | mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary | Q37346570 |
| | SEOM Clinical Guideline in ovarian cancer (2016) | Q37475168 |
| | Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression | Q38789527 |
| | Wogonin increases doxorubicin sensitivity by down-regulation of IGF-1R/AKT signaling pathway in human breast cancer | Q38814180 |
| | Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway | Q38925256 |
| | Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells | Q39047050 |
| | Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by wogonin via the PI3K/Akt pathway | Q39125279 |
| | Cisplatin nephrotoxicity: a review of the literature | Q39223600 |
| | Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells | Q39336106 |
| | Wogonin potentiates cisplatin-induced cancer cell apoptosis through accumulation of intracellular reactive oxygen species | Q39337101 |
| | JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells | Q39384513 |
| | Combined activity of oridonin and wogonin in advanced-stage ovarian cancer cells: sensitivity of ovarian cancer cells to phyto-active chemicals | Q39651374 |
| | Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway | Q40051078 |
| | Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells | Q46914709 |
| | Reversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cells. | Q53795106 |
| | Ovarian cancer statistics, 2018 | Q88890110 |
| | Anti-tumor activity of wogonin, an extract from Scutellaria baicalensis, through regulating different signaling pathways | Q89407909 |
| P921 | main subject | ovarian cancer | Q172341 |
| | wogonin | Q409606 |
| P304 | page(s) | 6007-6014 | |
| P577 | publication date | 2019-08-12 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Wogonin Increases Cisplatin Sensitivity in Ovarian Cancer Cells Through Inhibition of the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway | |
| P478 | volume | 25 | |